US Pharma Firms Forge Deals with Chinese Biotechs Amid Regulatory Pushback
U.S. pharmaceutical companies are accelerating partnerships with Chinese biotech firms even as regulators push for reduced dependence. Bristol-Myers Squibb is among those advancing collaborations.